Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration

SUMMARY STATEMENT: Intravitreal high dose (2 mg) ranibizumab may lead to quicker resolution of choroidal neovascularization (CNV) and associated retinal pigment epithelial detachment in eyes with exudative age-related macular degeneration, although it may possibly correlate with RPE tears in certain...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eye (Lond)
Päätekijät: Chan, C K, Abraham, P, Sarraf, D, Nuthi, A S D, Lin, S G, McCannel, C A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2015
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289828/
https://ncbi.nlm.nih.gov/pubmed/25277305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.233
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia